GlassScriptPhysician profile
Shireen Pais
NPI 1396709838
$89,260.35
in general payments reported to CMS, 2019-2025
31 companies · $6,715 in 2025
The $6,715 reported for 2025 was more than what 91% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,388 · 2020: $15K · 2021: $17K · 2022: $31K · 2023: $16K · 2024: $1,899 · 2025: $6,715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Consulting Fee: $4,500 · Travel and Lodging: $4,493 · Food and Beverage: $3,476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,500.00 |
| Consulting Fee | $4,500.00 |
| Travel and Lodging | $4,493.15 |
| Food and Beverage | $3,475.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $50,592.51 | 2019-2025 | General - Therapies, Exalt Model D, Axios |
| Abbvie INC. | $20,287.57 | 2019-2025 | |
| Olympus America INC. | $13,170.70 | 2019-2024 | Single Use Electrosurgical Knife Kd-655 |
| Olympus Corporation of The Americas | $2,710.83 | 2023-2025 | Single Use Electrosurgical Knife Kd-655, Disposable Distal Attachment, Olympus |
| Cook Medical LLC | $352.74 | 2023 | Hemospray |
| Erbe USA INC | $268.06 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $249.02 | 2019-2025 | Entyvio, Eohilia, Livtencity |
| Novo Nordisk INC | $205.80 | 2019 | |
| Conmed Corporation | $205.32 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $134.53 | 2019-2024 | Trulance, Plenvu, Xifaxan |
| Regeneron Healthcare Solutions, INC. | $133.73 | 2025 | Dupixent |
| Pfizer INC. | $125.00 | 2019 | |
| Qol Medical, LLC | $125.00 | 2023 | Sucraid |
| Medtronic, INC. | $106.56 | 2023 | Endoflip |
| W. L. Gore & Associates, INC. | $73.12 | 2024 | Gore Tag Conformable Thoracic Stent Graft |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $70.82 | 2019 | |
| Ardelyx, INC. | $62.20 | 2025 | Ibsrela |
| Aimmune Therapeutics, INC. | $56.93 | 2024-2025 | Zenpep |
| Janssen Biotech, INC. | $46.53 | 2022-2025 | Tremfya, Simponi, Stelara |
| Lilly USA, LLC | $46.38 | 2024-2025 | Omvoh |
| Alnylam Pharmaceuticals INC. | $38.88 | 2025 | Givlaari |
| Celgene Corporation | $33.27 | 2022-2024 | Zeposia |
| Ironwood Pharmaceuticals, INC | $22.48 | 2024 | |
| Madrigal Pharmaceuticals | $21.06 | 2025 | Rezdiffra |
| Celltrion USA INC. | $20.22 | 2024 | Zymfentra |
| Genzyme Corporation | $20.04 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $18.02 | 2019 | |
| Braintree Laboratories, INC. | $16.94 | 2019 | |
| Fujifilm Healthcare Americas Corporation | $16.60 | 2025 | |
| Ferring Pharmaceuticals INC. | $15.67 | 2019 | |
| Amgen INC. | $13.82 | 2023 | Avsola, Amjevita |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shireen Pais listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.